Kymera Therapeutics Stock Forecast

Buy or Hold candidate since Jun 11, 2026 Gain 26.87%

The Kymera Therapeutics Inc. stock price fell by -0.86% on the last day (Wednesday, 29th Jul 2026) from $106.16 to $105.25. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 3.99% from a day low at $104.12 to a day high of $108.27. The price has fallen in 6 of the last 10 days and is down by -7.77% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -190 thousand shares and in total, 490 thousand shares were bought and sold for approximately $51.56 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 51.14% during the next 3 months and, with a 90% probability hold a price between $149.50 and $194.40 at the end of this 3-month period.

KYMR Signals & Forecast

The Kymera Therapeutics Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $109.45. On a fall, the stock will find some support from the long-term average at approximately $105.19. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, July 10, 2026, and so far it has fallen -11.81%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Kymera Therapeutics Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $99.87 and $99.45. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Kymera Therapeutics Inc. finds support just below today's level at $99.87. If this is broken, then the next support from accumulated volume will be at $99.45 and $98.25.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $4.15 between high and low, or 3.99%. For the last week, the stock has had daily average volatility of 4.12%.

Our recommended stop-loss: $98.82 (-6.11%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 13 days ago.)

Trading Expectations (KYMR) For The Upcoming Trading Day Of Thursday 30th

For the upcoming trading day on Thursday, 30th we expect Kymera Therapeutics Inc. to open at $105.88, and during the day (based on 14 day Average True Range), to move between $102.56 and $107.94, which gives a possible trading interval of +/-$5.38 (+/-5.25%) up or down from last closing price. If Kymera Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 5.25% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $108.12 (2.73%) than the support at $99.87 (5.11%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Kymera Therapeutics Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Kymera Therapeutics Inc. stock to perform well in the short-term.

Current score: 1.389 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 30, 2026 - $105.88 ( 0.599%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk